{"slug":"tb-500-post-surgery","verification":{"valid":true,"entries":2,"head":"24db9dd307bf4189580346329f336d088e2dfa24c0a4ab87418d8031a9ef62dc"},"energy":{"passes":2,"tokens_in":32511,"tokens_out":3344,"tokens_total":35855,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"24db9dd307bf4189580346329f336d088e2dfa24c0a4ab87418d8031a9ef62dc"},"provenance":[{"ts":"2026-06-29T23:32:59.829Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Post Surgery\nSlug: tb-500-post-surgery\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stac","response":"{\n  \"slug\": \"tb-500-post-surgery\",\n  \"title\": \"TB-500 for Post-Surgery: Evidence-Graded Look at Repair-Cell Migration Pathways\",\n  \"body\": \"## What's breaking down\\n\\nAfter surgery, tissue layers face mechanical disruption, bleeding, and an inflammatory response. Repair cells must migrate to the wound site, reorganize the actin cytoskeleton for movement, clear debris, and lay down new matrix. If cell migration stalls or inflammation lingers, healing slows and scar tissue can form instead of functional repair. Post-surgical recovery hinges on whether regeneration outpaces ongoing breakdown at the incision or repair site.\\n\\n## Why TB-500 might help you\\n\\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\nTB-500 is a fragment studied to mimic parts of the natural thymosin beta-4 protein. In post-surgery contexts, the focus stays on helping cells reach the surgical site faster and supporting organized rebuilding rather than suppressing the overall healing signal.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **TB-500** → inflammation clearance / repair-cell migration\\n\\n## What the evidence actually shows\\n\\nHuman data on TB-500 or thymosin beta-4 for general post-surgical recovery remains limited. Most human work centers on ocular wounds and chronic skin ulcers. A 2015 phase 2 trial of thymosin beta-4 eye drops in dry eye patients reported a 35% drop in discomfort and 59% reduction in corneal staining versus placebo by day 56 (Sosne et al.). A 2021 phase 1 sa","tokens_in":32511,"tokens_out":3344,"cost":0,"prev":"genesis","hash":"8d65c778395a2c68f0068884f666924adf358f65ef8533c14849f613ffc2b027"},{"ts":"2026-07-17T02:42:17.809Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-post-surgery","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8d65c778395a2c68f0068884f666924adf358f65ef8533c14849f613ffc2b027","hash":"24db9dd307bf4189580346329f336d088e2dfa24c0a4ab87418d8031a9ef62dc"}]}